Clarity Pharmaceuticals Ltd.ASX: CU6

First patient dosed in Phase III prostate cancer trial

Dec 22, 2023 at 4:14 AM UTC · Issued by Clarity Pharmaceuticals Ltd.

Clarity Pharmaceuticals Ltd has released a press release.

View Attachment